vTv Therapeutics Inc. Amends By-Laws to Reduce Stockholder Quorum Requirement

vTv Therapeutics Inc. announced an amendment to its Second Amended and Restated By-Laws, specifically Section 2.8 of Article II. Effective December 19, 2025, the Board of Directors has reduced the quorum requirement for stockholder meetings to 33.4% of outstanding shares entitled to vote. This change aims to facilitate smoother transaction of business at meetings. The amendment, detailed in the First Amendment to the Second Amended and Restated By-Laws, will remain in effect alongside the existing by-laws. This filing was made on Form 8-K and includes the amendment as an exhibit.